Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Planning and development of CANTONE - C-peptide And Nephropathy in Type ONE diabetes

Reference number
Coordinator Cebix AB
Funding from Vinnova SEK 75 000
Project duration December 2010 - April 2011
Status Completed

Last updated 25 November 2019

Reference number 2011-00465